November 16, 2020 12:15 pm GMT
Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/JxBovaYwEtI/
Moderna reports its COVID-19 vaccine is 94.5% effective in first data from Phase 3 trial
Following fast on the heels of Pfizer’s announcement of its COVID-19 vaccine efficacy, Moderna is also sharing positive results from its Phase 3 trial on Monday. The biotech company says that its COVID-19 vaccine candidate has shown efficacy of 94.5% in its first interim data analysis, which covers 95 confirmed COVID cases among its study […]Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/JxBovaYwEtI/
Share this article:
Tweet
View Full Article
Techcrunch
TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.More About this Source Visit Techcrunch